Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Tiotropium + Formoterol QD vs Monotherapies in COPD
NCT02238119Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2002
- Primary completion
- Aug 2002
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tiotropium, formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Feb 2002; status: completed.
02
Drugs
tiotropiumformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02238119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02238119.